BACKGROUND: Cachexia worsens long-term prognosis of patients with heart failure (HF). Effective treatment of cachexia is missing. We seek to characterize mechanisms of cachexia in adipose tissue, which could serve as novel targets for the treatment. METHODS: The study was conducted in advanced HF patients (n = 52; 83% male patients) undergoing heart transplantation. Patients with ≥7.5% non-intentional body weight (BW) loss during the last 6 months were rated cachectic. Clinical characteristics and circulating markers were compared between cachectic (n = 17) and the remaining, BW-stable patients. In epicardial adipose tissue (EAT), expression of selected genes was evaluated, and a combined metabolomic/lipidomic analysis was performed to assess (i) the role of adipose tissue metabolism in the development of cachexia and (ii) potential impact of cachexia-associated changes on EAT-myocardium environment. RESULTS: Cachectic vs. BW-stable patients had higher plasma levels of natriuretic peptide B (BNP; 2007 ± 1229 vs. 1411 ± 1272 pg/mL; P = 0.010) and lower EAT thickness (2.1 ± 0.8 vs. 2.9 ± 1.4 mm; P = 0.010), and they were treated with ~2.5-fold lower dose of both β-blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACE/ARB-inhibitors). The overall pattern of EAT gene expression suggested simultaneous activation of lipolysis and lipogenesis in cachexia. Lower ratio between expression levels of natriuretic peptide receptors C and A was observed in cachectic vs. BW-stable patients (0.47 vs. 1.30), supporting activation of EAT lipolysis by natriuretic peptides. Fundamental differences in metabolome/lipidome between BW-stable and cachectic patients were found. Mitochondrial phospholipid cardiolipin (CL), specifically the least abundant CL 70:6 species (containing C16:1, C18:1, and C18:2 acyls), was the most discriminating analyte (partial least squares discriminant analysis; variable importance in projection score = 4). Its EAT levels were higher in cachectic as compared with BW-stable patients and correlated with the degree of BW loss during the last 6 months (r = -0.94; P = 0.036). CONCLUSIONS: Our results suggest that (i) BNP signalling contributes to changes in EAT metabolism in cardiac cachexia and (ii) maintenance of stable BW and 'healthy' EAT-myocardium microenvironment depends on the ability to tolerate higher doses of both ACE/ARB inhibitors and β-adrenergic blockers. In line with preclinical studies, we show for the first time in humans the association of cachexia with increased adipose tissue levels of CL. Specifically, CL 70:6 could precipitate wasting of adipose tissue, and thus, it could represent a therapeutic target to ameliorate cachexia.

Department of Cardiology Institute for Clinical and Experimental Medicine IKEM Prague Czech Republic

Institute of Physiology of the Czech Academy of Sciences Prague 4 Czech Republic

Zobrazit více v PubMed

Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 2007;116:627–636. PubMed

Horwich TB, Fonarow GC, Clark AL. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis 2018;61:151–156. PubMed

Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb‐Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997;349:1050–1053. PubMed

Melenovsky V, Kotrc M, Borlaug BA, Marek T, Kovar J, Malek I, et al. Relationships between right ventricular function, body composition, and prognosis in advanced heart failure. J Am Coll Cardiol 2013;62:1660–1670. PubMed

Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008;27:793–799. PubMed

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016;18:891–975. PubMed

Anker SD, Negassa A, Coats AJ, Afzal R, Poole‐Wilson PA, Cohn JN, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin‐converting‐enzyme inhibitors: an observational study. Lancet 2003;361:1077–1083. PubMed

Rohm M, Zeigerer A, Machado J, Herzig S. Energy metabolism in cachexia. EMBO Rep 2019;20:e47258. PubMed PMC

Rohm M, Schafer M, Laurent V, Ustunel BE, Niopek K, Algire C, et al. An AMP‐activated protein kinase‐stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice. Nat Med 2016;22:1120–1130. PubMed

Halle JL, Pena GS, Paez HG, Castro AJ, Rossiter HB, Visavadiya NP, et al. Tissue‐specific dysregulation of mitochondrial respiratory capacity and coupling control in colon‐26 tumor‐induced cachexia. Am J Physiol Regul Integr Comp Physiol 2019;317:R68–R82. PubMed

Szabo T, Postrach E, Mahler A, Kung T, Turhan G, von Haehling S, et al. Increased catabolic activity in adipose tissue of patients with chronic heart failure. Eur J Heart Fail 2013;15:1131–1137. PubMed

Fosshaug LE, Dahl CP, Risnes I, Bohov P, Berge RK, Nymo S, et al. Altered levels of fatty acids and inflammatory and metabolic mediators in epicardial adipose tissue in patients with systolic heart failure. J Card Fail 2015;21:916–923. PubMed

Jaffer I, Riederer M, Shah P, Peters P, Quehenberger F, Wood A, et al. Expression of fat mobilizing genes in human epicardial adipose tissue. Atherosclerosis 2012;220:122–127. PubMed

Kintscher U, Foryst‐Ludwig A, Haemmerle G, Zechner R. The role of adipose triglyceride lipase and cytosolic lipolysis in cardiac function and heart failure. Cell Rep Med 2020;1:1–21. PubMed PMC

Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol 2018;71:2360–2372. PubMed

Salatzki J, Foryst‐Ludwig A, Bentele K, Blumrich A, Smeir E, Ban Z, et al. Adipose tissue ATGL modifies the cardiac lipidome in pressure‐overload‐induced left ventricular failure. PLoS Genet 2018;14:e1007171. PubMed PMC

Doehner W, Frenneaux M, Anker SD. Metabolic impairment in heart failure: the myocardial and systemic perspective. J Am Coll Cardiol 2014;64:1388–1400. PubMed

Polak J, Kotrc M, Wedellova Z, Jabor A, Malek I, Kautzner J, et al. Lipolytic effects of B‐type natriuretic peptide 1‐32 in adipose tissue of heart failure patients compared with healthy controls. J Am Coll Cardiol 2011;58:1119–1125. PubMed

Moro C, Lafontan M. Natriuretic peptides and cGMP signaling control of energy homeostasis. Am J Physiol Heart Circ Physiol 2013;304:H358–H368. PubMed

Cabassi A, Coghi P, Govoni P, Barouhiel E, Speroni E, Cavazzini S, et al. Sympathetic modulation by carvedilol and losartan reduces angiotensin II‐mediated lipolysis in subcutaneous and visceral fat. J Clin Endocrinol Metab 2005;90:2888–2897. PubMed

Kovacova Z, Tharp WG, Liu D, Wei W, Xie H, Collins S, et al. Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes. Obesity (Silver Spring) 2016;24:820–828. PubMed PMC

Voros G, Ector J, Garweg C, Droogne W, Van Cleemput J, Peersman N, et al. Increased cardiac uptake of ketone bodies and free fatty acids in human heart failure and hypertrophic left ventricular remodeling. Circ Heart Fail 2018;11:e004953. PubMed

Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 2018;46:W486–W494. PubMed PMC

Wakai E, Aritake K, Urade Y, Fujimori K. Prostaglandin D2 enhances lipid accumulation through suppression of lipolysis via DP2 (CRTH2) receptors in adipocytes. Biochem Biophys Res Commun 2017;490:393–399. PubMed

Guauque‐Olarte S, Gaudreault N, Piche ME, Fournier D, Mauriege P, Mathieu P, et al. The transcriptome of human epicardial, mediastinal and subcutaneous adipose tissues in men with coronary artery disease. PLoS One 2011;6:e19908. PubMed PMC

Mracek T, Stephens NA, Gao D, Bao Y, Ross JA, Ryden M, et al. Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients. Br J Cancer 2011;104:441–447. PubMed PMC

Masoodi M, Kuda O, Rossmeisl M, Flachs P, Kopecky J. Lipid signaling in adipose tissue: connecting inflammation & metabolism. Biochim Biophys Acta 1851;2015:503–518. PubMed

Buresova J, Janovska P, Kuda O, Krizova J, der Stelt IR, Keijer J, et al. Postnatal induction of muscle fatty acid oxidation in mice differing in propensity to obesity: a role of pyruvate dehydrogenase. Int J Obes (Lond) 2018;44:235–244. PubMed

Funcke JB, Scherer PE. Beyond adiponectin and leptin: adipose tissue‐derived mediators of inter‐organ communication. J Lipid Res 2019;60:1648–1684. PubMed PMC

Dumas JF, Peyta L, Couet C, Servais S. Implication of liver cardiolipins in mitochondrial energy metabolism disorder in cancer cachexia. Biochimie 2013;95:27–32. PubMed

Peyta L, Jarnouen K, Pinault M, Coulouarn C, Guimaraes C, Goupille C, et al. Regulation of hepatic cardiolipin metabolism by TNFalpha: implication in cancer cachexia. Biochim Biophys Acta 2015;1851:1490–1500. PubMed

Julienne CM, Tardieu M, Chevalier S, Pinault M, Bougnoux P, Labarthe F, et al. Cardiolipin content is involved in liver mitochondrial energy wasting associated with cancer‐induced cachexia without the involvement of adenine nucleotide translocase. Biochim Biophys Acta 2014;1842:726–733. PubMed

Schlame M, Rua D, Greenberg ML. The biosynthesis and functional role of cardiolipin. Prog Lipid Res 2000;39:257–288. PubMed

Saini‐Chohan HK, Mitchell RW, Vaz FM, Zelinski T, Hatch GM. Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: thematic review series: genetics of human lipid diseases. J Lipid Res 2012;53:4–27. PubMed PMC

Li J, Romestaing C, Han X, Li Y, Hao X, Wu Y, et al. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab 2010;12:154–165. PubMed PMC

Zhu HJ, Ding HH, Deng JY, Pan H, Wang LJ, Li NS, et al. Inhibition of preadipocyte differentiation and adipogenesis by zinc‐alpha2‐glycoprotein treatment in 3T3‐L1 cells. J Diabetes Investig 2013;4:252–260. PubMed PMC

Rognstad R, Katz J. The effect of 2,4‐dinitrophenol on adipose‐tissue metabolism. Biochem J 1969;111:431–444. PubMed PMC

Rossmeisl M, Syrovy I, Baumruk F, Flachs P, Janovska P, Kopecký J. Decreased fatty acid synthesis due to mitochondrial uncoupling in adipose tissue. FASEB J 2000;14:1793–1800. PubMed

Szeto HH, Liu S. Cardiolipin‐targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging. Arch Biochem Biophys 2018;660:137–148. PubMed

von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019. J Cachexia Sarcopenia Muscle 2019;10:1143–1145. PubMed PMC

Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure

BCAA metabolism in pancreatic cancer affects lipid balance by regulating fatty acid import into mitochondria

Hydrophilic Interaction Liquid Chromatography-Hydrogen/Deuterium Exchange-Mass Spectrometry (HILIC-HDX-MS) for Untargeted Metabolomics

Omega-3 PUFAs prevent bone impairment and bone marrow adiposity in mouse model of obesity

Human bone marrow stromal cells: the impact of anticoagulants on stem cell properties

LORA, Lipid Over-Representation Analysis Based on Structural Information

Exploring the Impact of Organic Solvent Quality and Unusual Adduct Formation during LC-MS-Based Lipidomic Profiling

Antioxidant Role and Cardiolipin Remodeling by Redox-Activated Mitochondrial Ca2+-Independent Phospholipase A2γ in the Brain

Knock-Out of ACBD3 Leads to Dispersed Golgi Structure, but Unaffected Mitochondrial Functions in HEK293 and HeLa Cells

Biochemical Background in Mitochondria Affects 2HG Production by IDH2 and ADHFE1 in Breast Carcinoma